These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 26553164)
1. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis. Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164 [TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease. Attia ; Ahmed H; Gadelkarim M; Morsi M; Awad K; Elnenny M; Ghanem E; El-Jaafary S; Negida A CNS Neurol Disord Drug Targets; 2017; 16(2):169-175. PubMed ID: 27823574 [TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. ; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS; Ravina B; Shults CM; Helles K; Snively V; Lew MF; Griebner B; Watts A; Gao S; Pourcher E; Bond L; Kompoliti K; Agarwal P; Sia C; Jog M; Cole L; Sultana M; Kurlan R; Richard I; Deeley C; Waters CH; Figueroa A; Arkun A; Brodsky M; Ondo WG; Hunter CB; Jimenez-Shahed J; Palao A; Miyasaki JM; So J; Tetrud J; Reys L; Smith K; Singer C; Blenke A; Russell DS; Cotto C; Friedman JH; Lannon M; Zhang L; Drasby E; Kumar R; Subramanian T; Ford DS; Grimes DA; Cote D; Conway J; Siderowf AD; Evatt ML; Sommerfeld B; Lieberman AN; Okun MS; Rodriguez RL; Merritt S; Swartz CL; Martin WR; King P; Stover N; Guthrie S; Watts RL; Ahmed A; Fernandez HH; Winters A; Mari Z; Dawson TM; Dunlop B; Feigin AS; Shannon B; Nirenberg MJ; Ogg M; Ellias SA; Thomas CA; Frei K; Bodis-Wollner I; Glazman S; Mayer T; Hauser RA; Pahwa R; Langhammer A; Ranawaya R; Derwent L; Sethi KD; Farrow B; Prakash R; Litvan I; Robinson A; Sahay A; Gartner M; Hinson VK; Markind S; Pelikan M; Perlmutter JS; Hartlein J; Molho E; Evans S; Adler CH; Duffy A; Lind M; Elmer L; Davis K; Spears J; Wilson S; Leehey MA; Hermanowicz N; Niswonger S; Shill HA; Obradov S; Rajput A; Cowper M; Lessig S; Song D; Fontaine D; Zadikoff C; Williams K; Blindauer KA; Bergholte J; Propsom CS; Stacy MA; Field J; Mihaila D; Chilton M; Uc EY; Sieren J; Simon DK; Kraics L; Silver A; Boyd JT; Hamill RW; Ingvoldstad C; Young J; Thomas K; Kostyk SK; Wojcieszek J; Pfeiffer RF; Panisset M; Beland M; Reich SG; Cines M; Zappala N; Rivest J; Zweig R; Lumina LP; Hilliard CL; Grill S; Kellermann M; Tuite P; Rolandelli S; Kang UJ; Young J; Rao J; Cook MM; Severt L; Boyar K JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227 [TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials. Zhu ZG; Sun MX; Zhang WL; Wang WW; Jin YM; Xie CL Neurol Sci; 2017 Feb; 38(2):215-224. PubMed ID: 27830343 [TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 for Parkinson's disease. Liu J; Wang L; Zhan SY; Xia Y Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420 [TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease. Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881 [TBL] [Abstract][Full Text] [Related]
7. Effects of coenzyme Q10 supplementation on inflammation, angiogenesis, and oxidative stress in breast cancer patients: a systematic review and meta-analysis of randomized controlled- trials. Alimohammadi M; Rahimi A; Faramarzi F; Golpour M; Jafari-Shakib R; Alizadeh-Navaei R; Rafiei A Inflammopharmacology; 2021 Jun; 29(3):579-593. PubMed ID: 34008150 [TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Coenzyme Q10 for Parkinson's disease. Liu J; Wang LN; Zhan SY; Xia Y Cochrane Database Syst Rev; 2012 May; 2012(5):CD008150. PubMed ID: 22592726 [TBL] [Abstract][Full Text] [Related]
9. Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease? Seet RC; Lim EC; Tan JJ; Quek AM; Chow AW; Chong WL; Ng MP; Ong CN; Halliwell B Antioxid Redox Signal; 2014 Jul; 21(2):211-7. PubMed ID: 24410614 [TBL] [Abstract][Full Text] [Related]
10. The effects of coenzyme Q10 supplementation on biomarkers of inflammation and oxidative stress in among coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Jorat MV; Tabrizi R; Kolahdooz F; Akbari M; Salami M; Heydari ST; Asemi Z Inflammopharmacology; 2019 Apr; 27(2):233-248. PubMed ID: 30758695 [TBL] [Abstract][Full Text] [Related]
11. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials. Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M Pharmacol Res; 2019 Oct; 148():104290. PubMed ID: 31185284 [TBL] [Abstract][Full Text] [Related]
12. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Shults CW; Oakes D; Kieburtz K; Beal MF; Haas R; Plumb S; Juncos JL; Nutt J; Shoulson I; Carter J; Kompoliti K; Perlmutter JS; Reich S; Stern M; Watts RL; Kurlan R; Molho E; Harrison M; Lew M; Arch Neurol; 2002 Oct; 59(10):1541-50. PubMed ID: 12374491 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of acupuncture combined with Madopar for Parkinson's disease: a systematic review with meta-analysis. Liu H; Chen L; Zhang Z; Geng G; Chen W; Dong H; Chen L; Zhan S; Li T Acupunct Med; 2017 Dec; 35(6):404-412. PubMed ID: 29180347 [TBL] [Abstract][Full Text] [Related]
14. The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Jorat MV; Tabrizi R; Mirhosseini N; Lankarani KB; Akbari M; Heydari ST; Mottaghi R; Asemi Z Lipids Health Dis; 2018 Oct; 17(1):230. PubMed ID: 30296936 [TBL] [Abstract][Full Text] [Related]
15. The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Bakhshayeshkaram M; Lankarani KB; Mirhosseini N; Tabrizi R; Akbari M; Dabbaghmanesh MH; Asemi Z Curr Pharm Des; 2018; 24(31):3710-3723. PubMed ID: 30417782 [TBL] [Abstract][Full Text] [Related]
17. Chinese medicine for idiopathic Parkinson's disease: A meta analysis of randomized controlled trials. Wei W; Chen HY; Fan W; Ye SF; Xu YH; Cai J Chin J Integr Med; 2017 Jan; 23(1):55-61. PubMed ID: 27796824 [TBL] [Abstract][Full Text] [Related]
18. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM; JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047 [TBL] [Abstract][Full Text] [Related]
19. Diabetes, Age, and Duration of Supplementation Subgroup Analysis for the Effect of Coenzyme Q10 on Oxidative Stress: A Systematic Review and Meta-Analysis. Hajiluian G; Heshmati J; Jafari Karegar S; Sepidarkish M; Shokri A; Shidfar F Complement Med Res; 2021; 28(6):557-570. PubMed ID: 33866314 [TBL] [Abstract][Full Text] [Related]
20. H. pylori and Parkinson's disease: Meta-analyses including clinical severity. Dardiotis E; Tsouris Z; Mentis AA; Siokas V; Michalopoulou A; Sokratous M; Dastamani M; Bogdanos DP; Deretzi G; Kountouras J Clin Neurol Neurosurg; 2018 Dec; 175():16-24. PubMed ID: 30308319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]